Traffic Lights Intervention Reduces Therapeutic Inertia: A Randomized Controlled Trial in Multiple Sclerosis Care

Otros/as autores/as

Institut Català de la Salut

[Saposnik G] Division of Neurology, Department of Medicine, St. Michael's Hospital, Toronto, Canada. University of Toronto, Toronto, Canada. [Mamdani M] Li Ka Shing Centre for Healthcare Analytics Research and Training (LKS-CHART), Toronto, Toronto, Canada. [Montalban X] Servei de Neurologia I Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya, Barcelona, Spain. Hospital Universitari Vall d'Hebron, Barcelona, Spain. [Terzaghi M] Decision Neuroscience Unit, Li Ka Shing Knowledge Institute, Toronto, Canada. St. Michael's Hospital, Toronto, Canada. University of Toronto, Toronto, Canada. [Silva B, Saladino ML] Institute of Neuroscience Buenos Aires (INEBA), Buenos Aires, Argentina.

Vall d'Hebron Barcelona Hospital Campus

Fecha de publicación

2019-07-19T08:33:00Z

2019-07-19T08:33:00Z

2019-06-21



Resumen

Decision making; Disease-modifying therapy; Multiple sclerosis


Toma de decisiones; Terapia modificadora de la enfermedad; Esclerosis múltiple


Presa de decisions; Teràpia modificadora de la malaltia; Esclerosi múltiple


Background: Therapeutic inertia (TI) is a common phenomenon among physicians who care for patients with chronic conditions. We evaluated the efficacy of the traffic light system (TLS) educational intervention to reduce TI among neurologists with MS expertise. Methods: In this randomised, controlled trial, 90 neurologists who provide care to MS patients were randomly assigned to the TLS intervention (n = 45) or to the control group (n = 45). The educational intervention employed the TLS, a behavioral strategy that facilitates therapeutic choices by facilitating reflective decisions. The TLS consisted in a short, structured, single session intervention of 5-7 min duration. Participants made therapeutic choices of 10 simulated case-scenarios. The primary outcome was a reduction in TI based on a published TI score (case-scenarios in which a participant showed TI divided by the total number of scenarios where TI was possible ranging from 0 to 8). Results: All participants completed the study and were included in the primary analysis. TI was lower in the TLS group (1.47, 95% CI 1.32-1.61) compared to controls (1.93; 95% CI 1.79-2.08). The TLS group had a lower prevalence of TI compared to controls (0.67, 95% CI 0.62-0.71 vs. 0.82, 95% CI 0.78-0.86; p = 0.001). The multivariate analysis, adjusted for age, specialty, years of practice, and risk preference showed a 70% reduction in TI for the TLS intervention compared to controls (OR 0.30; 95% CI 0.10-0.89). Conclusions: In this randomized trial, the TLS strategy decreases the incidence of TI in MS care irrespective of age, expertise, years for training, and risk preference of participants, which would lead to better patient outcomes.

Tipo de documento

Artículo


Versión publicada

Lengua

Inglés

Publicado por

SAGE Publications

Documentos relacionados

MDM Policy and Practice;4(1)

https://journals.sagepub.com/doi/10.1177/2381468319855642

Citación recomendada

Esta citación se ha generado automáticamente.

Derechos

Attribution-NonCommercial 4.0 International

http://creativecommons.org/licenses/by-nc/4.0/

Este ítem aparece en la(s) siguiente(s) colección(ones)